Favorites Sign in
  1. Home
  2. Companies
  3. Stock Regeneron Pharmaceuticals
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals REGN

$ 904.05 -2.95%
report update icon

Quarterly report 2026-Q2
added 07-30-2026

Country

 usaUSA

IPO year

 1991

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBALSPB

Shares

 105 M

Market Cap[1]

 $ 94.6 B

EBITDA (LTM)

 $ 4.12 B

P/E (LTM)

 19.218017

P/S (LTM)

 6.036402

EPS (LTM)

 43.07

Regeneron Pharmaceuticals is an American biotechnology company that specializes in the development and production of innovative medical treatments. The company was founded in 1988 in New York.

Regeneron Pharmaceuticals' main areas of focus are research and development of drugs for the treatment of various diseases, including oncological, autoimmune, infectious, and others.

One of the company's most well-known products is Eylea, which is used to treat age-related macular degeneration. In addition, Regeneron Pharmaceuticals is developing drugs for the treatment of cancer, Alzheimer's disease, Parkinson's disease, and other conditions.

The company invests heavily in scientific research and development to create innovative and effective drugs. Regeneron Pharmaceuticals collaborates with universities, research centers, and other companies to expand its scientific potential and improve its products.

Regeneron Pharmaceuticals has a wide network of distributors and partners around the world, enabling it to provide its products to patients in various countries. The company strives for continuous improvement of its products and expansion of its activities to meet the needs of patients worldwide.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Trevena Trevena
TRVN
 		- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Immunovant Immunovant
IMVT
 		$ 28.43 -4.92 % $ 5.19 B Nasdaq Global Select Market usaUSA
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
 		- -45.12 % $ 2.85 M Nasdaq Global Select Market usaUSA
Oncorus Oncorus
ONCR
 		- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
Y-mAbs Therapeutics Y-mAbs Therapeutics
YMAB
 		- - $ 382 M Nasdaq Global Select Market,SPB usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
 		- -2.99 % $ 2.47 M NYSE American usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
 		$ 13.1 -26.38 % $ 54.5 M Nasdaq Capital Market canadaCanada
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		- - $ 23.9 M Nasdaq Global Select Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Satsuma Pharmaceuticals Satsuma Pharmaceuticals
STSA
 		- -0.9 % $ 36.5 M Nasdaq Global Market usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
 		$ 1.1 -12.7 % $ 93.8 M Nasdaq Capital Market usaUSA
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
 		- - $ 3.48 B Nasdaq Global Select Market,SPB usaUSA
Metacrine Metacrine
MTCR
 		- - $ 24.2 M Nasdaq Global Select Market usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
 		- -0.13 % $ 3.73 B Nasdaq Global Select Market,SPB usaUSA
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
 		- -46.98 % $ 3.57 M Nasdaq Global Select Market usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
 		- 31.87 % $ 1.61 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
Evelo Biosciences Evelo Biosciences
EVLO
 		- -14.46 % $ 27.9 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Morphic Holding Morphic Holding
MORF
 		- - $ 2.42 B Nasdaq Global Market usaUSA
Novan Novan
NOVN
 		- -24.84 % $ 2.64 M Nasdaq Capital Market usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
 		- -15.0 % $ 3.04 M Nasdaq Global Select Market usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
 		- -9.21 % $ 2.55 M Nasdaq Global Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
BELLUS Health BELLUS Health
BLU
 		- - $ 2.47 B Nasdaq Global Select Market canadaCanada
bluebird bio bluebird bio
BLUE
 		- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
 		- - $ 13.6 B Nasdaq Global Select Market,SPB usaUSA
IGM Biosciences IGM Biosciences
IGMS
 		- - $ 76.9 M Nasdaq Global Select Market,SPB usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
 		- - $ 29.6 M Nasdaq Global Select Market usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
 		- - $ 216 M Nasdaq Global Market usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		- - $ 35.4 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
 		- - $ 728 M Nasdaq Global Select Market usaUSA
Rubius Therapeutics Rubius Therapeutics
RUBY
 		- -33.55 % $ 7.81 M Nasdaq Global Select Market usaUSA
Aptinyx Aptinyx
APTX
 		- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
TRACON Pharmaceuticals TRACON Pharmaceuticals
TCON
 		- -1.38 % $ 46.8 M Nasdaq Capital Market usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
 		- - $ 3.3 B Nasdaq Global Select Market,SPB usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
 		- - $ 309 M Nasdaq Global Select Market usaUSA
Allogene Therapeutics Allogene Therapeutics
ALLO
 		$ 1.09 -8.82 % $ 240 M Nasdaq Global Select Market,SPB usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
 		- -37.48 % $ 476 K Nasdaq Capital Market usaUSA
Epizyme Epizyme
EPZM
 		- - $ 249 M Nasdaq Global Select Market usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
 		- -9.72 % $ 5.89 M Nasdaq Capital Market usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
 		$ 1.86 -4.07 % $ 2.44 M Nasdaq Global Select Market usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
 		- -0.75 % $ 18.7 M Nasdaq Capital Market danmarkDanmark
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		- 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		- - $ 154 M Nasdaq Capital Market usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
 		- - $ 300 M Nasdaq Global Select Market usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
 		- - $ 4.55 M Nasdaq Global Select Market irlandaIrlanda
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
 		- - $ 643 M Nasdaq Global Select Market,SPB usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
 		- - $ 127 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.